Home health remedies Strides buys soft gel capsule facility in U.S.

Strides buys soft gel capsule facility in U.S.

65
0
SHARE

Strides Pharma has picked up a soft gel manufacturing facility in the U.S. from Micelle BioPharma for very little but intends to invest in it. 

The Indian drugmaker said today that it bought the Riviera Beach, Florida facility for $500,000 but will invest another $10 million to add other capabilities. It said it is one of the very few manufacturing plants in the U.S. with a soft gel capsule suite for formulations with containment. It also said it has the only  FDA  approved integrated manufacturing‐packaging SGC facility in the U.S.

RELATED: FDA investigators discover key Strides Pharma quality records in shredding room

Strides, which now has eight formulation facility globally, the facility has passed several U.S. inspections.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

That is not true of all of Strides’ other facilities. The FDA last month issued a warning letter to one of Strides’ facilities in India. The agency said the drug testing records at a Strides Pharma plant in a shredding room, indicating the facilities had been data integrity issues, as well as other problems. 

Source link